Anti-Kv1.4 antibody-associated myocarditis refractory to maintenance immunosuppressive therapy: a case report

European Heart Journal - Case Reports

2 November 2026
Organised by: Logo
ESC Journals HEART FAILURE Acute Heart Failure

Abstract

AbstractBackground

Anti-Kv1.4 antibody-associated myocarditis is an extremely rare condition and its optimal long-term management remains unclear.

Case summary

A 66-year-old woman presented with myasthenia gravis-like symptoms, marked creatine kinase elevation, leukopenia, and hypogammaglobulinaemia. She developed acute myocarditis with ventricular arrhythmias and a reduced left ventricular ejection fraction. Intravenous immunoglobulin and corticosteroid therapy resulted in rapid clinical and cardiac improvement. During cautious tapering of oral prednisolone, she was readmitted with febrile neutropenia and subsequently developed progressive ventricular dysfunction and cardiogenic shock. Cardiac magnetic resonance imaging demonstrated extensive myocardial fibrosis, and autopsy revealed diffuse lymphocytic infiltration. Post-mortem testing confirmed positivity for anti-Kv1.4 antibodies.

Discussion

This case highlights the potentially fatal course of suspected anti-Kv1.4 antibody-associated inflammatory myocardial disease despite an initial favourable response to immunosuppressive therapy. It illustrates the diagnostic and therapeutic challenges of distinguishing immune-mediated progression from other causes of myocardial injury and implies the need for individualized long-term management strategies.

Contributors

Hiroyuki Watanabe
Hiroyuki Watanabe

Author

Akita University Graduate School of Medicine Akita , Japan